Crystal Structure
Crystallisation Method: X-ray
Corresponding Chain: B
Sequence Length: 456-574
Detail: Struture Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0155 | ||||
Gene Name | SLC22B3 | ||||
Protein Name | Synaptic vesicle glycoprotein 2C | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Crystal Structure Crystallisation Method: X-ray Corresponding Chain: B Sequence Length: 456-574 Detail: Struture Info |
||||
Synonyms | KIAA1054; SV2C; Synaptic vesicle glycoprotein SV2C | ||||
DT Family | Major Facilitator Superfamily (MFS) | ||||
Vesicular Neurotransmitter Transporter (VNT) Family (Related to the SP Family | |||||
Function | This transporter positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles. | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Dopamine
|
Approved | Drug Info | Parkinson's Disease | 8A00.0 | [1] |
References | |||||
1 | Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2253-E2262. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.